Navigation Links
Plasma in bags
Date:11/11/2011

Physicians are increasingly using live cells in their treatments: in blood transfusions and bone marrow transplants, as well as in stem cell therapies and following severe burns. Cells taken from the patients themselves are ideal for replacing burned skin, eliminating immune deficiencies, repairing degenerated cartilage or to treat injured bones as they are not rejected by the immune system. These cells have to be kept, cultivated, reproduced or even modified in a patient-specific manner. The problem, however, lies in the storability of the cell solutions used. As they can easily become infected by germs, they can only be stored for a few days in the containers conventionally used today. The joint project InnoSurf aims to remedy this problem: scientists from five research institutions, along with partners in the industry have developed innovative plastic surfaces and measuring methods for efficiently producing human cells for diagnostic and therapeutic applications. The work was coordinated by the Helmholz Centre for Infection Research (HZI) in Braunschweig, Germany.

The idea is to cultivate the cells in sealed, sterile plastic bags. The inner surface of the bags has to be modified so that they provide cells with good conditions for survival. A team led by Dr. Michael Thomas at the Fraunhofer Institute for Surface Engineering and Thin Films IST in Braunschweig, Germany, has now developed a plasma technology process for use at atmospheric pressure. "We fill the bags with a specific gas mixture and apply an electrical voltage" explains scientific assistant Dr. Kristina Lachmann. "Inside them, for a brief period, plasma is created, i.e. a luminescent, ionized gas, which chemically alters the plastic surface". During this process the bag remains sterile as plasmas also have a disinfecting action. "The advantage of the process is that it operates at atmospheric pressure and is therefore cost-effective, fast and flexible" emphasizes group leader Dr. Michael
'/>"/>

Contact: Dr. Michael Thomas
michael.thomas@ist.fraunhofer.de
49-531-215-5525
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2

Related biology news :

1. RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
2. MIT researchers study the danger of toxoplasma parasites
3. Scripps Research scientists redefine the role of plasma cells in the immune system
4. Grant advances quark-gluon plasma studies

5. Atmospheric pressure plasma jet from a grounded electrode
6. Toxoplasma gondii spreads in the habitat of the Iberian lynx
7. Modeling Toxoplasma focus of workshop
8. Plasma produces KO cocktail for MRSA
9. How Toxoplasma gondii gets noticed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plasma in bags
(Date:12/10/2014)... DUBLIN , Dec. 08, 2014 Research ... announced the addition of the "Biometrics Market ... http://photos.prnewswire.com/prnh/20130307/600769 ... for projects such as rural banking and upgradation ... major trends witnessed in the market. Besides the ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical ... and Prevention (CDC) have reported the identification of ... range of influenza A viruses, including avian influenza ... some seasonal influenza viruses. These antibodies have the ...
... BKYI) today announced plans to release fourth quarter 2008 financial results on ... the release, BIO-key has scheduled a conference call, which will be broadcast ... Eastern Time., What: ... ...
... species, known scientifically as Diporeia , is,related to ... the Great Lakes, say NOAA scientists. As invasive mussel ... many aquatic species have steadily and unilaterally declined. ... Laboratory published,this week in Freshwater Biology documents ...
Cached Biology News:Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 3BIO-key(R) Announces Fourth Quarter and 2008 Year-End Earnings Release and Conference Call Schedule 2
(Date:12/19/2014)... Dec. 18, 2014   ISN has released ... Performance Indicators publication series. With data aggregated ... reported in 2013 within its online contractor management platform, ... key performance indicator (KPI) statistics. The ... publication is available in two industry specific ...
(Date:12/17/2014)... Based on the revenues gained ... market is dominated by four major players contributing ... These players include GE Healthcare (U.K.), Siemens AG ... , Full Report Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html ... be attributed to its strong product portfolio, which ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
Breaking Biology Technology:ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2
... Shamir,Optical Industry Ltd. (Nasdaq: SHMR ) ("Shamir"), ... the progressive ophthalmic lens,market, announced today that its ... an aggregate amount of US$ 4.0 million (approximately ... representative rate of,exchange), or approximately US$ 0.243 (approximately ...
... The American Cancer Society Estimates Approximately 20,000 Patients are ... Diagnosed With Brain Cancer Each Year in the ... January 14, Rosetta Genomics, Ltd. (Nasdaq: ROSG ), ... today it has signed a collaboration agreement with the ...
... Bio-Based Technologies to ... Meet Growing Global Demand, ... named Nicholas C. Fanandakis group vice president - DuPont Applied,BioSciences. ... efforts to commercialize a range of bio-based,products and technologies to ...
Cached Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 4DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences 2
Sequencing and primer design rolled into one. Just give us your clone and a reference sequence, and we'll do the rest. Single-strand or double-strand coverage. Guaranteed results....
...
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
... microplate coating using advanced automated high throughput microplate processing equipment ... can also accommodate virtually any lot size of the following ... 8 and 12 well strips, ... 384 well microplate, ...
Biology Products: